header
February 26, 2021

In This Issue
BREAKING: Washington Post Reports, “FDA advisers recommend authorization of Johnson & Johnson single-dose coronavirus vaccine”
BREAKING: Maine Adopts Age-based Approach to Expanding Vaccine Eligibility
Committee Delays Debate on Bill to Eliminate Nurse Practitioner Training
“Community Based Collaboration Form” Vaccine Request Available from Maine DHHS/CDC
Maine PMP to Stay with Appriss System
CMS Special Enrollment Period for Marketplace Coverage 2021
Sue Woods, MD, MPH-- Internet connectivity that just works will help Maine thrive
Incoming MMA President, Jeffrey Barkin, MD, DFAPA on WGAN Radio
Next MMA Legislative Call Will Be Wednesday, March 3rd
Daniel Hanley Center for Health Leadership’s Renowned Physician Executive Leadership Institute – The Advanced Course Enrollment is OPEN
PPE Available Through the MMA & ActionPPE
A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
Maine Legislature Week 7 Update
Maine Legislature: Public Hearings & Work Sessions
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
Suicide Prevention and Management in Healthcare Practice Settings: A Comprehensive Evidence-Based Approach
Maine CDC Annual Prevention Professionals Conference - March 2nd-3rd
AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Nursing Director
Medical Director - Bucksport Regional Health Center
Rangeley Family Medicine seeks Physician
Nurse Practitioner
Physician
Psychiatric Nurse Practitioner

 
Search Back Issues



 

 

 


Follow Us:
BREAKING: Washington Post Reports, “FDA advisers recommend authorization of Johnson & Johnson single-dose coronavirus vaccine”

According to Post reports, “An expert committee unanimously recommended Friday that the Food and Drug Administration authorize a coronavirus vaccine from Johnson & Johnson, making it all but certain there will soon be a third vaccine in the United States, the first to require just a single shot.” 

The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorized for emergency use in the U.S. It's the next step in a process that could end with the new vaccine's rollout early next week.

 

 

 

 

 

 

Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©